Literature DB >> 31594107

[Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31594107     DOI： 10.3760/cma.j.issn.1001-0939.2019.10.006

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN： 1001-0939


× No keyword cloud information.
  3 in total

1.  The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology.

Authors:  Yanhua Song; Guirong Wang; Qiang Li; Rongmei Liu; Liping Ma; Qi Li; Mengqiu Gao
Journal:  Infect Drug Resist       Date:  2021-01-29       Impact factor: 4.003

2.  The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant Mycobacterium tuberculosis Strains.

Authors:  Xia-Li Lyu; Ting-Ting Lin; Jing-Tao Gao; Hong-Yan Jia; Chuan-Zhi Zhu; Zi-Hui Li; Jing Dong; Qi Sun; Wei Shu; Li-Ping Pan; Zong-De Zhang; Qi Li
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

3.  Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Authors:  Xubin Zheng; Lina Davies Forsman; Ziwei Bao; Yan Xie; Zhu Ning; Thomas Schön; Judith Bruchfeld; Biao Xu; Jan-Willem Alffenaar; Yi Hu
Journal:  Eur Respir J       Date:  2022-03-24       Impact factor: 16.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.